Professor Peter Szlosarek
Professor Szlosarek is an Oncologist in Hertfordshire.
Based At
NHS base
Barts Health NHS Trust
GMC Number
4119371
Clinic Timetable
Clinical interests
Skin tumours, cancer, oncology, thoracic oncological surgery. Professor Szlosarek has a further clinical interest in melanoma, lung cancer and mesothelioma.
Professional Memberships
Academic Background
Professor Szlosarek graduated from Kings College, London in 1994 with degrees in Pharmacology,Medicine and Surgery. He received the Pharmacology and Therapeutics Intercalated BSc Prize and Legg Prize in Surgical Pathology.
He obtained the MRCP in 1997 and subsequently trained in medical oncology at St. George's,Guy's and St. Bartholomew's Hospitals. Following a substantive NHS oncology consultant post, Professor Szlosarek rejoined the Barts Cancer Institute as a Principal Investigator in 2008. His translational lab program focuses on aberrant tumour metabolism and inflammation and is closely allied to my clinical interests in the treatment of mesothelial, lung and skin cancers.
Professor Szlosarek is involved in both undergraduate and postgraduate education with publications in Cancer Research, Clinical Cancer Research, Lancet Oncology and Journal of Clinical Oncology. His work has been presented at various international conferences with invited lectures in the US, Europe and Asia.
Based at
NHS base
Barts Health NHS Trust
GMC Number
4119371
Clinic Timetable
Clinical interests
Skin tumours, cancer, oncology, thoracic oncological surgery. Professor Szlosarek has a further clinical interest in melanoma, lung cancer and mesothelioma.
Professional Memberships
Academic Background
Professor Szlosarek graduated from Kings College, London in 1994 with degrees in Pharmacology,Medicine and Surgery. He received the Pharmacology and Therapeutics Intercalated BSc Prize and Legg Prize in Surgical Pathology.
He obtained the MRCP in 1997 and subsequently trained in medical oncology at St. George's,Guy's and St. Bartholomew's Hospitals. Following a substantive NHS oncology consultant post, Professor Szlosarek rejoined the Barts Cancer Institute as a Principal Investigator in 2008. His translational lab program focuses on aberrant tumour metabolism and inflammation and is closely allied to my clinical interests in the treatment of mesothelial, lung and skin cancers.
Professor Szlosarek is involved in both undergraduate and postgraduate education with publications in Cancer Research, Clinical Cancer Research, Lancet Oncology and Journal of Clinical Oncology. His work has been presented at various international conferences with invited lectures in the US, Europe and Asia.